BusinessHemispherx Biopharma Announces Extension of Rintatolimod European Early Access Program (EAP) to Pancreatic Cancer PatientsBy Nasdaq OMXJan 11, 2017, 1:31 PM UTC
BusinessOncoMed Presents Interim Phase 1b Data for Ipafricept and Vantictumab in Pancreatic Cancer at the ESMO 2016 CongressBy Nasdaq OMXOct 10, 2016, 12:30 PM UTC
BusinessOncoMed to Present Clinical Data for Wnt Inhibitors at the ESMO 2016 CongressBy Nasdaq OMXSep 29, 2016, 12:31 PM UTC
BusinessOncoMed to Present Clinical Data for Wnt Inhibitors at the ESMO 2016 CongressBy Nasdaq OMXSep 29, 2016, 12:31 PM UTC
BusinessOncoMed Pharmaceuticals Completes Enrollment of Phase 2 YOSEMITE Clinical Trial of Demcizumab in Pancreatic CancerBy Nasdaq OMXSep 1, 2016, 12:01 PM UTC
BusinessOncoMed Presents Updated Phase 1b Data for Demcizumab in First-Line Pancreatic Cancer at the Gastrointestinal Cancers SymposiumBy Nasdaq OMXJan 22, 2016, 1:30 PM UTC
